Name:
Lead subacetate
Synonym:
Basic lead acetate; Lead, bis(acetato)tetrahydroxytri-; Bis(aceto)dihydroxytrilead;Bis(acetato)tetrahydroxytrilead; Lead acetate, basic; Lead, bis-(acetato-O)tetrahydroxytri-; Lead monosubacetate; Lead subacetate; Monobasic lead acetate
CAS:
1335-32-6
Section 1 - Chemical Product
MSDS Name:Lead subacetate
Synonym:Basic lead acetate; Lead, bis(acetato)tetrahydroxytri-; Bis(aceto)dihydroxytrilead;Bis(acetato)tetrahydroxytrilead; Lead acetate, basic; Lead, bis-(acetato-O)tetrahydroxytri-; Lead monosubacetate; Lead subacetate; Monobasic lead acetate
Synonym:Basic lead acetate; Lead, bis(acetato)tetrahydroxytri-; Bis(aceto)dihydroxytrilead;Bis(acetato)tetrahydroxytrilead; Lead acetate, basic; Lead, bis-(acetato-O)tetrahydroxytri-; Lead monosubacetate; Lead subacetate; Monobasic lead acetate
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 1335-32-6 | Lead subacetate | 100 | 215-630-3 |
| Hazard Symbols: T N Risk Phrases: 33 40 48/22 61 62 50/53 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Danger of cumulative effects. Limited evidence of a carcinogenic effect. Harmful : danger of serious damage to health by prolonged exposure if swallowed. May cause harm to the unborn child. Possible risk of impaired fertility. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.Air sensitive.
Potential Health Effects
Eye:
Causes eye irritation. Causes redness and pain.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful amounts. Causes redness and pain. If absorbed, may cause symptoms similar to those for ingestion.
Ingestion:
Harmful if swallowed. May cause severe and permanent damage to the digestive tract. May cause severe digestive tract irritation with abdominal pain, nausea, vomiting and diarrhea. Ingestion of lead compounds can cause toxic effects in the blood-forming organs, kidneys and central nervous system. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to those described for ingestion.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Chronic inhalation and ingestion may cause effects similar to those of acute inhalation and ingestion. Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Lead salts have been reported to cross the placenta and induce embryo- and feto- mortality. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.
Danger of cumulative effects. Limited evidence of a carcinogenic effect. Harmful : danger of serious damage to health by prolonged exposure if swallowed. May cause harm to the unborn child. Possible risk of impaired fertility. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.Air sensitive.
Potential Health Effects
Eye:
Causes eye irritation. Causes redness and pain.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful amounts. Causes redness and pain. If absorbed, may cause symptoms similar to those for ingestion.
Ingestion:
Harmful if swallowed. May cause severe and permanent damage to the digestive tract. May cause severe digestive tract irritation with abdominal pain, nausea, vomiting and diarrhea. Ingestion of lead compounds can cause toxic effects in the blood-forming organs, kidneys and central nervous system. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to those described for ingestion.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Chronic inhalation and ingestion may cause effects similar to those of acute inhalation and ingestion. Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Lead salts have been reported to cross the placenta and induce embryo- and feto- mortality. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with pre-existing kidney, nerve or circulatory disorders or with skin or eye problems may be more susceptible to the effects of this substance.
Antidote: The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with pre-existing kidney, nerve or circulatory disorders or with skin or eye problems may be more susceptible to the effects of this substance.
Antidote: The use of d-Penicillamine as a chelating agent should be determined by qualified medical personnel. The use of Dimercaprol or BAL (British Anti-Lewisite) as a chelating agent should be determined by qualified medical personnel.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Dust can be an explosion hazard when exposed to heat or flame.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Dust can be an explosion hazard when exposed to heat or flame.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Place under an inert atmosphere.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Place under an inert atmosphere.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Handle under an inert atmosphere. Store protected from air.
Storage:
Store in a tightly closed container. Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible substances. Do not expose to air. Store under an inert atmosphere.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Handle under an inert atmosphere. Store protected from air.
Storage:
Store in a tightly closed container. Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible substances. Do not expose to air. Store under an inert atmosphere.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1335-32-6: United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3 (as Pb) United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m TWA (as Pb) France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le compounds, as Pb) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1335-32-6: United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3 (as Pb) United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m TWA (as Pb) France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb) Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le compounds, as Pb) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Powder
Color: white
Odor: odorless
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble in cold water.
Specific Gravity/Density:
Molecular Formula: C4H10O8Pb3
Molecular Weight: 807.69
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Takes up CO2 from air and becomes incompletely soluble.
Conditions to Avoid:
Dust generation, exposure to air, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, acids, active metals, bromates, phenols, potassium, hydrogen peroxide, sodium, sulfides (inorganic, e.g. ferric sulfide, lead sulfide, sodium sulfide), sulfites, phosphates, carbonates, chloral hydrate, alkalis, resorcinol, tannin, air, salicylic acid, vegetable infusions, citrates, chlorides, tartrates.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, lead/lead oxides.
Hazardous Polymerization: Will not occur.
Stable under normal temperatures and pressures. Takes up CO2 from air and becomes incompletely soluble.
Conditions to Avoid:
Dust generation, exposure to air, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, acids, active metals, bromates, phenols, potassium, hydrogen peroxide, sodium, sulfides (inorganic, e.g. ferric sulfide, lead sulfide, sodium sulfide), sulfites, phosphates, carbonates, chloral hydrate, alkalis, resorcinol, tannin, air, salicylic acid, vegetable infusions, citrates, chlorides, tartrates.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, lead/lead oxides.
Hazardous Polymerization: Will not occur.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1335-32-6: OF8750000 LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Lead subacetate - California: carcinogen, initial date 10/1/89 NTP: Suspect carcinogen (listed as Lead compounds).
Other:
See actual entry in RTECS for complete information.
CAS# 1335-32-6: OF8750000 LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Lead subacetate - California: carcinogen, initial date 10/1/89 NTP: Suspect carcinogen (listed as Lead compounds).
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III
USA RQ: CAS# 1335-32-6: 10 lb final RQ; 4.54 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 33 Danger of cumulative effects.
R 40 Limited evidence of a carcinogenic effect.
R 48/22 Harmful : danger of serious damage to health
by prolonged exposure if swallowed.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 1335-32-6: No information available.
Canada
CAS# 1335-32-6 is listed on Canadas DSL List.
CAS# 1335-32-6 is listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1335-32-6 is listed on the TSCA inventory.
